BAM
Blueshift Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,475
| Closed | -$251K | – | 725 |
|
|
2022
Q1 | $251K | Buy |
+19,475
| New | +$251K | 0.02% | 669 |
|
|
2021
Q2 | – | Sell |
-31,995
| Closed | -$467K | – | 938 |
|
|
2021
Q1 | $467K | Buy |
+31,995
| New | +$467K | 0.05% | 488 |
|
|
2020
Q1 | – | Sell |
-13,150
| Closed | -$237K | – | 270 |
|
|
2019
Q4 | $237K | Buy |
+13,150
| New | +$237K | 0.03% | 678 |
|